🇺🇸 NKT2152 in United States

NKT2152 (nkt2152) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

NKT2152 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is NKT2152 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for NKT2152 in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.